Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticles. [electronic resource]
Producer: 20181211Description: 457 p. digitalISSN:- 1471-2407
- Animals
- Antigens, Neoplasm -- genetics
- Antineoplastic Agents, Immunological -- administration & dosage
- Biomarkers, Tumor
- Carcinoma, Pancreatic Ductal -- drug therapy
- Cell Line, Tumor
- Cell Survival
- Disease Models, Animal
- Drug Liberation
- Endocytosis
- Female
- Gene Expression
- Humans
- Mice
- Molecular Targeted Therapy
- Mucin-1 -- immunology
- Nanoparticles -- chemistry
- Paclitaxel -- administration & dosage
- Pancreatic Neoplasms -- drug therapy
- Polyethylene Glycols -- chemistry
- Polylactic Acid-Polyglycolic Acid Copolymer
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.